FDA Gives Sponsors Two Years to Transition to New Data Submission Standards

Drug Industry Daily
As the FDA moves to update and standardize data submission standards for NDAs, ANDAs, INDs and BLAs, it’s warning sponsors they will only have two years to come into compliance once guidance is finalized later this year.

To View This Article:


Subscribe To Drug Industry Daily